{"version":"1.0","provider_name":"Site da Brakke Consulting","provider_url":"https:\/\/brakkeconsulting.com\/pt","title":"News from Brakke Consulting","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"9wxxbifYzT\"><a href=\"https:\/\/brakkeconsulting.com\/pt\/22123\/\">Not\u00edcias e notas de sa\u00fade animal de 26 de julho de 2002<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/brakkeconsulting.com\/pt\/22123\/embed\/#?secret=9wxxbifYzT\" width=\"600\" height=\"338\" title=\"&#8220;Animal Health News &#038; Notes for July 26, 2002&#8221; &#8212; Brakke Consulting Website\" data-secret=\"9wxxbifYzT\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script type=\"text\/javascript\">\n\/* <![CDATA[ *\/\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/\/# sourceURL=https:\/\/brakkeconsulting.com\/wp-includes\/js\/wp-embed.min.js\n\/* ]]> *\/\n<\/script>","description":"****************************************************************** Brakke Consulting&rsquo;s Animal Health News &amp; Notes for July 26, 2002 Copyright &copy; Brakke Consulting, Inc. ****************************************************************** COMPANY EARNINGS RELEASES &gt;&nbsp; Pfizer reported that Animal Health sales in the second quarter 2002 increased 11% to $274 million (up 15% excluding the impact of foreign exchange), compared to the same period in 2001. This strong performance reflected double-digit growth in both livestock and companion animal product lines. Revolution, Rimadyl, Dectomax and RespiSure\/Stellamune showed strong sales growth. Sales for the first six months of 2002 increased 10% to $513 million. (company website) &gt;&nbsp; Akzo Nobel reported that for the second quarter 2002, its animal healthcare business Intervet was severely impacted by incidental items (especially obsolete inventories), weak currencies and market conditions in Latin America. (company website) &gt;&nbsp; Wyeth reported that second quarter 2002 sales of its animal health division Fort Dodge were $194 million, an increase of 1% over sales in the second quarter 2001.&nbsp; Sales for the first six months were flat at $355 million.&nbsp; The company reported that sales of West Nile Virus vaccine offset decreases in ProHeart 6 sales. (company website) &gt;&nbsp; Eli Lilly reported that second quarter 2002 sales of its animal health division Elanco were $162 million, an increase of 4% compared with the second quarter of 2001. Excluding the effect of exchange rates, sales grewView Full Post;"}